AXSOME THERAPEUTICS BUSINESS MODEL CANVAS TEMPLATE RESEARCH B_43 Licensing ensures compliance with regulatory

Licensing ensures compliance with regulatory standards

Such partnerships are crucial for market penetration

by 2026 trials emphasize 5-year graft survival and ex-vivo organ repair/gene-therapy feasibility with ~$18M in collaborative research grants committed

and managing extensive information

cutting logistics CO2 by an estimated 18% and reducing lead costs ~12% versus centralized production

AXSOME THERAPEUTICS BUSINESS MODEL CANVAS TEMPLATE RESEARCH B_43 Licensing ensures compliance with regulatoryAxsome Therapeutics BMC: Strategic Blueprint for CNS Value, Partners, and Revenue Unlock the full strategic blueprint behind Axsome Therapeutics's business model: this concise Business Model Canvas maps value propositions, target patient and payer segments, key partnerships, and revenue levers that drive growth in CNS therapeutics. Partnerships Strategic Licensing with Pfizer for Sunosi Rights Axsome Therapeutics acquired global rights to Sunosi from